Priority Date: 23.02.12 (JP 20120037448)

COMBINED ANTICANCER DRUG SENSITIVITY-DETERMINING MARKER

  • Application ID: EP13752246
  • Status: GRANT OF PATENT INTENDED

Applicants

Research organisation logo small
Research Organisation
Technology company logo small
Technology Company

Attorney

operating since 1970
Headquarter in Munich
active in Legal Services and IP Consulting

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and G01 (MEASURING; TESTING) is specialized in the combination A61 and G01. We found, that Coller IP Management Ltd, TransMIT GmbH, Kailuweit & Uhlemann, Bock Bieber Donath, Dr. Emil Benatov & Partners - Bulgarian Patent Attorney & Licensed Appraiser and 169 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 23.02.2012 - Priority Date (JP 20120037448)
  • 29.08.2013 - Publication A1 (WO2013125675)
  • 31.12.2014 - Publication A1 (EP2818870)